Chorea: Clinical Trials

7 trials for Chorea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Unknown 7
Phase 21Unknown 1

Follow Chorea: new trials by email Literature Review of Chorea trials Research Report on Chorea

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Symptomatic Therapy for Patients With Huntington's Disease
Haloperidol 2Mg Tab, Risperidone 1Mg Tab, Zoloft 50Mg Tablet - Huntington Disease
Phase 1UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine602020-03-122021-04-02
Nilotinib in Huntington's Disease
Nilotinib 150 MG - Huntington Disease
Phase 1UnknownGeorgetown University102018-11-152020-02-20
CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects
CKD-504, Placebo - Huntington Disease
Phase 1UnknownChong Kun Dang Pharmaceutical882018-05-232020-02-24
Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease
Cellavita HD Lower Dose, Cellavita HD Higher dose - Huntington Disease
Phase 1UnknownAzidus Brasil62017-10-162022-11-02
Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.
autologous Stem Cell - Huntington Disease
Phase 1 / Phase 2UnknownChaitanya Hospital, Pune502014-09-012014-09-17
Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD)
Far Infrared Radiation - Huntington Disease
Phase 1UnknownGAAD Medical Research Institute Inc.52008-05-012009-01-05
Ursodiol in Huntington's Disease
ursodiol, placebo - Huntington Disease
Phase 1UnknownOregon Health and Science University212007-08-012009-02-05

Narrower conditions

Huntington Disease (7)

Broader conditions

Basal Ganglia Diseases (7)  ·  Brain Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Cognition Disorders (7)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7)  ·  Dementia (7)  ·  Dyskinesias (7)  ·  Genetic Diseases, Inborn (7)  ·  Heredodegenerative Disorders, Nervous System (7)  ·  Mental Disorders (7)  ·  Movement Disorders (7)  ·  Nervous System Diseases (7)  ·  Neurocognitive Disorders (7)  ·  Neurodegenerative Diseases (7)

Interventions

CKD-504 (1)  ·  Cell- and Tissue-Based Therapy (1)  ·  Haloperidol (1)  ·  Histone Deacetylase Inhibitors (1)  ·  Risperidone (1)  ·  Sertraline (1)  ·  Tablets (1)  ·  Ursodeoxycholic Acid (1)  ·  deutetrabenazine (1)  ·  idebenone (1)  ·  nilotinib (1)

Sponsors

Azidus Brasil (1)  ·  Chaitanya Hospital, Pune (1)  ·  Chong Kun Dang Pharmaceutical (1)  ·  GAAD Medical Research Institute Inc. (1)  ·  Georgetown University (1)  ·  Oregon Health and Science University (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

United States (2)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  India (1)  ·  South Korea (1)

Top investigators

Joyce Macedo da Silva, MD (1)  ·  Ken Nedd, M.D. (1)  ·  Kyung-Sang Yu (1)  ·  Penelope Hogarth, M.D. (1)  ·  Zhi-Ying Wu (1)

Results publications

PMID 27434297, PMID 41188963